Novacyt S.A.

Company Profile

Company website
Medical Equipment and Services (Medical Equipment)

Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing. 

Investor Access

28 Sep
Event information

The Company will be announcing Its unaudited financial results for the six months ended 30 June 2023 on Thursday, 28 September 2023,

Investors can sign up to Investor Meet Company for free and add to meet Novacyt via the following link:   

Thursday, 28 September 2023 at 12:30pm

Financial Calendar
 Event Date
Year EndDecember
Half  Year EndJune
Preliminary Results*April
Interim Results*September

* Months based on previous announcements of this kind